NCT02150408View on ClinicalTrials.gov

Evaluation of PET-CT Using Somatostatin Agonists Labeled With Gallium68 in Neuroendocrine Tumors

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

April 22, 2014

Primary Completion Date

May 24, 2017

Study Completion Date

April 5, 2023

Conditions
Gastro-Entero-Pancreatic Tumors (GEPs)
Interventions
OTHER

PET-CT

Trial Locations (1)

13005

Assistance Publique Hopitaux de Marseille, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT02150408 - Evaluation of PET-CT Using Somatostatin Agonists Labeled With Gallium68 in Neuroendocrine Tumors | Biotech Hunter | Biotech Hunter